Juan Francisco Palma‐Ordóñez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Juan Francisco Palma‐Ordóñez has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ana María Moreno-Fernández
Departamento de Citologia e Histologia Normal y Patologica, Facultad de Medicina, Universidad de Sevilla, Spain
1 shared publication - Antonio Martínez-Lara
Pronacera, Avenida de la Ingeniería 9, Local 34, Parque Empresarial Arte Sacro (PEASS), 41015 Seville, Spain
1 shared publication - David Cotán
Pronacera Therapeutics S.L. Seville Spain
1 shared publication - Elena Durán-González
Pronacera, Avenida de la Ingeniería 9, Local 34, Parque Empresarial Arte Sacro (PEASS), 41015 Seville, Spain
1 shared publication - Jorge Antolín Ramírez Tejero
Departamento de Biología Experimental, Centro de Estudios Avanzados en Olivar y Aceites de Oliva, Universidad de Jaén, Jaén 23071, Spain
1 shared publication
Latest Publications
- Open Access
- 26 January 2024
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 27 (1) , e15021
Implication of intestinal microbiota in the etiopathogenesis of fibromyalgia: A systematic review
Fibromyalgia (FM) is a highly prevalent chronic disease. About 4.7% of the world's population suffers from generalized pain and hypersensitivity, in addition to a wide range of physical and psychological symptoms. The etiopathogenesis of this disease is multifactorial, which makes its diagnosis and treatment challenging. Recently, the increase in the number of studies on microbiota has provided new data that can help to understand the onset and development of FM. An updated systematic review of the causes of FM has been carried out in this work. Particularly in the last decade, research has focused on the gut–brain axis, which has emerged as a crucial mechanism for microbiota‐host crosstalk. In FM patients, quantitative imbalances of the intestinal microbiota (dysbiosis) and bacterial metabolites with differential relative abundance have been found, especially short‐chain fatty acids and lipopolysaccharides. Furthermore, the microbiota has been found to indirectly influence host neurotransmitter mechanisms, mainly through the serotonin precursor, glutamate, and gamma‐aminobutyric acid. Thus, all these mechanisms and their influence on the etiopathogenesis of FM are discussed in this review.
- 26 January 2024
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 27 (1) , e15021
Open AccessImplication of intestinal microbiota in the etiopathogenesis of fibromyalgia: A systematic review
Fibromyalgia (FM) is a highly prevalent chronic disease. About 4.7% of the world's population suffers from generalized pain and hypersensitivity, in addition to a wide range of physical and psychological symptoms. The etiopathogenesis of this disease is multifactorial, which makes its diagnosis and treatment challenging. Recently, the increase in the number of studies on microbiota has provided new data that can help to understand the onset and development of FM. An updated systematic review of the causes of FM has been carried out in this work. Particularly in the last decade, research has focused on the gut–brain axis, which has emerged as a crucial mechanism for microbiota‐host crosstalk. In FM patients, quantitative imbalances of the intestinal microbiota (dysbiosis) and bacterial metabolites with differential relative abundance have been found, especially short‐chain fatty acids and lipopolysaccharides. Furthermore, the microbiota has been found to indirectly influence host neurotransmitter mechanisms, mainly through the serotonin precursor, glutamate, and gamma‐aminobutyric acid. Thus, all these mechanisms and their influence on the etiopathogenesis of FM are discussed in this review.